117 related articles for article (PubMed ID: 2313144)
1. [Clinical significance of CA19-9 for endometriosis].
Watanabe J; Johboh T; Hata H; Kuramoto H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):155-61. PubMed ID: 2313144
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
Toki T; Kubota J; Lu X; Nakayama K
Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis].
Kobayashi H; Kanayama N; Hayata T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1054-60. PubMed ID: 3475378
[TBL] [Abstract][Full Text] [Related]
4. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma].
Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical analysis of CA19-9, SLX, and CA125 in adenoid cystic carcinoma of trachea and bronchus].
Tamura S; Yamaguchi K; Terada M; Nakano T; Maeda J; Iwahashi N; Hada T; Higashino K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Mar; 30(3):407-11. PubMed ID: 1314919
[TBL] [Abstract][Full Text] [Related]
8. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.
Takeshima N; Shimizu Y; Umezawa S; Hirai Y; Chen JT; Fujimoto I; Yamauchi K; Hasumi K
Gynecol Oncol; 1994 Sep; 54(3):321-6. PubMed ID: 8088608
[TBL] [Abstract][Full Text] [Related]
9. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
11. [The mechanism of the increase in the serum CA125 concentration in patients with endometriosis].
Kobayashi H; Miyake W; Yamashita M; Kanayama N; Hayata T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):467-72. PubMed ID: 3163715
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
[TBL] [Abstract][Full Text] [Related]
14. [Primary research on saliva and serum CA125 assays for detecting malignant ovarian tumors].
Chen DX; Li FQ
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):84-5, 123-4. PubMed ID: 2364796
[TBL] [Abstract][Full Text] [Related]
15. [A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].
Nakamura H; Katsumi T; Nagata S; Saito M; Konaka C; Kato H
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1425-29. PubMed ID: 9567093
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
Harada T; Kubota T; Aso T
Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between tumor markers and clinical symptoms in ovarian cancer].
Yakushiji M; Nishimura H
Rinsho Byori; 1992 Apr; 40(4):354-8. PubMed ID: 1593760
[TBL] [Abstract][Full Text] [Related]
20. Significant increases in serum CA125 and CA19-9 following torsion from an adenofibroma of the ovary: a case report.
Fujiwara K; Moriya T; Mikami Y; Hiratsuka J; Sawada S; Imajo Y; Kohno I
Jpn J Clin Oncol; 1994 Apr; 24(2):116-9. PubMed ID: 8158859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
